Europe Infusion Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The Europe infusion devices market is projected to grow significantly, reaching approximately USD 6,590.36 million by 2031, up from USD 4,047.05 million in 2023, with a compound annual growth rate (CAGR) of 6.3% during this period.

Executive Summary and Market Analysis

The market is divided into several key regions, including Germany, the UK, France, Spain, Italy, and the Rest of Europe. The growth of the infusion devices market in Europe is primarily driven by the increasing use of infusion devices, particularly infusion pumps, for managing chronic conditions such as cancer, diabetes, and circulatory diseases. Additionally, strategic initiatives by companies, such as geographical expansion, are further propelling market growth. For example, in January 2024, Medtronic plc received CE Mark approval for its MiniMed 780G insulin pump system, which includes a disposable continuous glucose monitor (CGM), set to be released in Europe in the summer of 2024.

Market Segmentation Analysis

The Europe infusion devices market can be analyzed through various segments, including product type, application, and end user.

Product Type: The market is categorized into infusion pumps and infusion sets, with infusion pumps dominating the market share in 2023. Within infusion pumps, volumetric pumps, syringe pumps, insulin pumps, patient-controlled analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps are included, with volumetric pumps holding the largest share. Infusion sets are further divided into vented and non-vented sets, with vented sets leading in market share.
Application: The market is segmented by application into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others, with diabetes being the largest segment in 2023.
End User: The end users of infusion devices include hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others, with hospitals and specialty clinics accounting for the largest share in 2023.

Market Outlook

The global increase in life expectancy is contributing to a growing geriatric population, which is expected to drive demand for infusion devices. According to the World Health Organization (WHO), by 2030, one in six people will be aged 60 or older, with the number of individuals aged 60 and above projected to rise from one billion in 2020 to 2.1 billion by 2050. Notably, Europe and Asia have the highest proportions of elderly populations, with countries like Japan and Italy leading in the percentage of seniors.

Infusion therapy offers several benefits for older adults, including:

Rehydration and Electrolyte Balance: Older adults are at a higher risk of dehydration, and infusion therapy can help maintain hydration and electrolyte levels.
Improved Nutritional Status: Infusion therapy can deliver essential nutrients directly into the bloodstream, aiding those who struggle with nutrient absorption due to age.
Enhanced Immune Function: Infusion therapy can provide immune-boosting nutrients, which are crucial for older adults who are more susceptible to infections.
Pain Management: Infusion therapy can effectively manage chronic pain by delivering medications directly into the bloodstream, improving the quality of life for seniors.

Country Insights

The market analysis by country reveals that Germany held the largest share in 2023. The prevalence of chronic diseases, particularly diabetes and cancer, is rising in Germany. According to the IDF Diabetes Atlas, the number of individuals with diabetes in Germany was 6.12 million in 2021, projected to increase to 6.5 million by 2030. The use of insulin pump therapy among children and adolescents has also seen significant growth, indicating a strong market potential for infusion devices in the country.

Company Profiles

Key players in the Europe infusion devices market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd. These companies are focusing on strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe infusion devices market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe infusion devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe infusion devices market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution. Show more